GM $NSPX mentioned in market watch pipeline review! https://www.marketwatch.com/press-release/bone-marrow-transplant-rejection---pipeline-review-h1-2019-key-players-cellect-biotechnology-cellective-biotherapy-cellix-bioclinigen-group-compugen-2019-05-23